share_log

Stocks of the Hour: QX Resources, Chimeric Therapeutics, Peako, IVE Group

Stocks of the Hour: QX Resources, Chimeric Therapeutics, Peako, IVE Group

熱門股票:QX Resources、Chimeric Therapeutics、Peako、IVE 集團
sharecafe ·  2023/10/25 08:50

To register for Friday's webinar click here.

要註冊參加週五的網路研討會,請單擊此處。

QX Resources (ASX:QXR) has commenced drilling at the Liberty Lithium Brine Project in California, USA. QXR Managing Director, Stephen Promnitz, said, "this is potentially a new large-scale lithium brine project - in the heartland of a rapidly growing battery supply chain in the USA. Participants in the USA are aggressively seeking to secure domestic battery minerals supply to balance potential supply side risks to the energy transition." Shares are trading 4.55 per cent higher at 2.3 cents.

QX Resources(澳大利亞證券交易所股票代碼:QXR)已開始在美國加利福尼亞州的Liberty鋰鹵水專案進行鑽探。董事董事總經理史蒂芬·普羅姆尼茨表示:“這可能是一個新的大型鋰鹽水專案--位於美國快速增長的電池供應鏈的核心地帶。美國的參與者正在積極尋求確保國內電池礦物供應,以平衡能源轉型帶來的潛在供應側風險。”該公司股價上漲4.55%,至2.3美分。

Chimeric Therapeutics (ASX:CHM) has announced a non-renounceable entitlement offer to raise up to approximately $10 million (before direct offer costs). The offer price is $0.028 per new share, a 31.7% discount to the closing price of Chimeric shares on 24 October 2023.Shares are trading 26.83 per cent lower at 3 cents.

奇美爾治療公司(澳大利亞證券交易所代碼:CHM)宣佈了一項不可放棄的權利要約,將籌集至多約1000萬美元(未扣除直接要約成本)。發行價為每股新股0.028美元,較2023年10月24日嵌合體股票的收盤價折讓31.7%。股票交易價格下跌26.83%,至3美分。

Peako (ASX:PKO) announced that their RC drilling increases the strike length of higher-grade mineralisation at the Brumby Prospect from 180m to 680m. Commenting on the results, Peako Executive Director Rae Clark stated, "Importantly the shallow plunging PGE mineralisation remains open down plunge to the south-west." Shares are trading 33.33 per cent higher at 0.8 cents.

Peako(澳大利亞證券交易所股票代碼:PKO)宣佈,他們的RC鑽探將Brumby Prospects的高品位礦化的走向長度從180米增加到680米。董事高管雷·克拉克在對結果發表評論時表示:“重要的是,淺層俯衝的鉑族元素礦化仍然向西南傾斜。”該公司股價上漲33.33%,至0.8美分。

IVE Group (ASX:IGL) announces entry into the fibre based packaging sector with the strategic acquisition of JacPak, for a total purchase consideration of $35 million. Commenting on the acquisition of JacPak, IVE Group CEO Matt Aitken said, "Over the last two years we have communicated our strategic intention to enter the short to medium run folding cartons segment of the Australian packaging sector." Shares are trading 1.71 per cent higher at $1.785.

艾維集團(澳大利亞證券交易所股票代碼:IGL)宣佈戰略收購JacPak,進入基於纖維的包裝領域,總收購對價為3500萬美元。在評論收購JacPak時,Ive Group首席執行官馬特·艾特肯表示:“在過去的兩年裡,我們已經傳達了我們進入澳大利亞包裝行業中短期至中期折疊紙箱領域的戰略意圖。”該公司股價上漲1.71%,至1.785美元。

1x1.png?futu_img_keep_extra_domain=1

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論